Literature DB >> 16761154

Autologous blood transfusion following total knee arthroplasty: is it always necessary?

N Tellisi1, R Kakwani, N Hulse, G Abusitta, N Ashammakhi, K A H Wahab.   

Abstract

A retrospective study of 85 patients undergoing primary total knee replacement (TKR), who also received autologous blood transfusion (ABT) to compensate for the perioperative blood loss. In our series 16.4% of the patients needed allogenic blood transfusion. Of the remaining 83.4% only 49.5% received autologous transfusion. Autologous transfusion was withheld in 34.1% of cases either because the blood volume was inadequate or because the collection time exceeded the recommended time limit. The mean haemoglobin (Hb) level with or without autologous transfusion was 10 g, raising the question of the necessity of using autologous transfusion in primary total TKR.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16761154      PMCID: PMC3172766          DOI: 10.1007/s00264-006-0109-8

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  18 in total

1.  Re-transfusion of autologous blood from wound drains: the means for reducing transfusion requirements in total knee arthroplasty.

Authors:  V K Peter; M Radford; M G Matthews
Journal:  Knee       Date:  2001-12       Impact factor: 2.199

2.  Reinfusion of drained blood as an alternative to homologous blood transfusion after total knee replacement.

Authors:  A Sinha; M Sinha; S Burgert
Journal:  Int Orthop       Date:  2001       Impact factor: 3.075

3.  An algorithm to reduce allogenic red blood cell transfusions for major orthopedic surgery.

Authors:  Robert Slappendel; Ris Dirksen; Eric W G Weber; Dick B van der Schaaf
Journal:  Acta Orthop Scand       Date:  2003-10

4.  An analysis of blood management in patients having a total hip or knee arthroplasty.

Authors:  B E Bierbaum; J J Callaghan; J O Galante; H E Rubash; R E Tooms; R B Welch
Journal:  J Bone Joint Surg Am       Date:  1999-01       Impact factor: 5.284

5.  Survival and half-life of red cells salvaged after hip and knee replacement surgery.

Authors:  J Umlas; M S Jacobson; S V Kevy
Journal:  Transfusion       Date:  1993-07       Impact factor: 3.157

6.  Preoperative hemoglobin levels and the need for transfusion after prosthetic hip and knee surgery: analysis of predictive factors.

Authors:  Jose A Salido; Luis A Marín; Luis A Gómez; Pedro Zorrilla; Cristóbal Martínez
Journal:  J Bone Joint Surg Am       Date:  2002-02       Impact factor: 5.284

7.  Autotransfusion of drainage blood in arthroplasty. A prospective, controlled study of 31 operations.

Authors:  P W Kristensen; L S Sørensen; H C Thyregod
Journal:  Acta Orthop Scand       Date:  1992-08

8.  Postoperative collection and reinfusion of autologous blood in total knee arthroplasty.

Authors:  R S Majkowski; I C Currie; J H Newman
Journal:  Ann R Coll Surg Engl       Date:  1991-11       Impact factor: 1.891

9.  An evaluation of the efficacy of postoperative blood salvage after total joint arthroplasty. A prospective randomized trial.

Authors:  D M Gannon; A V Lombardi; T H Mallory; B K Vaughn; C R Finney; S Niemcryk
Journal:  J Arthroplasty       Date:  1991-06       Impact factor: 4.757

10.  A strategy for reducing blood-transfusion requirements in elective orthopaedic surgery. Audit of an algorithm for arthroplasty of the lower limb.

Authors:  A T Helm; M T Karski; S J Parsons; J S Sampath; R S Bale
Journal:  J Bone Joint Surg Br       Date:  2003-05
View more
  2 in total

1.  Unwashed shed blood: should we transfuse it?

Authors:  Giancarlo Maria Liumbruno; Jonathan H Waters
Journal:  Blood Transfus       Date:  2011-04-20       Impact factor: 3.443

2.  Comparison of therapeutic effects between drainage blood reinfusion and temporary clamping drainage after total knee arthroplasty in patients with rheumatoid arthritis.

Authors:  Bin Li; Zhong-tang Liu; Peng Shen; Bing-zheng Zhou; Lun-hao Bai
Journal:  Clinics (Sao Paulo)       Date:  2015-03-01       Impact factor: 2.365

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.